Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma

Edward Wolfgang Lee, Sarah Khan

Clin Mol Hepatol. 2017;23(4):265-272. Published online November 8, 2017

DOI: https://doi.org/10.3350/cmh.2017.0111

View: 10978 Download: 359 Web of Science: 39 Crossref: 35

Editorial

Surveillance of hepatocellular carcinoma: is only ultrasound enough?

Woo Kyoung Jeong

Clin Mol Hepatol. 2017;23(3):222-223. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0046

View: 6513 Download: 162 Web of Science: 7 Crossref: 6

Original Article

Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B

Won Sohn, Ju-Yeon Cho, Ji Hoon Kim, Jung Il Lee, Hyung Joon Kim, Min-Ah Woo, Sin-Ho Jung, Yong-Han Paik

Clin Mol Hepatol. 2017;23(2):170-178. Published online May 16, 2017

DOI: https://doi.org/10.3350/cmh.2016.0086

View: 9416 Download: 221 Web of Science: 50 Crossref: 44

Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion

Jihyun An, Kwang Sun Lee, Kang Mo Kim, Do Hyun Park, Sang Soo Lee, Danbi Lee, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee

Clin Mol Hepatol. 2017;23(2):160-169. Published online May 16, 2017

DOI: https://doi.org/10.3350/cmh.2016.0088

View: 8726 Download: 239 Web of Science: 31 Crossref: 26

Meta-analysis of the correlation between the rs17401966 polymorphism in kinesin family member 1B and susceptibility to hepatitis B virus related hepatocellular carcinoma

Mingkuan Su, Jianfeng Guo, Jiancheng Huang

Clin Mol Hepatol. 2017;23(2):138-146. Published online April 21, 2017

DOI: https://doi.org/10.3350/cmh.2016.0083

View: 9005 Download: 112 Web of Science: 4 Crossref: 3

Editorial

Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?

Do Young Kim

Clin Mol Hepatol. 2017;23(2):123-124. Published online June 23, 2017

DOI: https://doi.org/10.3350/cmh.2017.0107

View: 6793 Download: 118

Review

Radioembolization for the treatment of hepatocellular carcinoma

Hyo-Cheol Kim

Clin Mol Hepatol. 2017;23(2):109-114. Published online May 10, 2017

DOI: https://doi.org/10.3350/cmh.2017.0004

View: 12281 Download: 362 Web of Science: 46 Crossref: 41

Liver Imaging

Aggressive tumor recurrence after radiofrequency ablation for hepatocellular carcinoma

Tae Wook Kang, Hyo Keun Lim, Dong Ik Cha

Clin Mol Hepatol. 2017;23(1):95-101. Published online March 24, 2017

DOI: https://doi.org/10.3350/cmh.2017.0006

View: 11098 Download: 257 Web of Science: 39 Crossref: 35

Editorial

Is scheduled second chemoembolization necessary for early stage hepatocellular carcinoma showing complete response after first chemoembolization?

Jin Wook Chung

Clin Mol Hepatol. 2017;23(1):31-33. Published online March 16, 2017

DOI: https://doi.org/10.3350/cmh.2017.0102

View: 6001 Download: 104 Web of Science: 1 Crossref: 1

Liver Imaging

Percutaneous cryoablation for hepatocellular carcinoma

Kyoung Doo Song

Clin Mol Hepatol. 2016;22(4):509-515. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0079

View: 11966 Download: 210 Web of Science: 38 Crossref: 41

Original Article

Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma

Ju-Yeon Cho, Moon Seok Choi, Gil Sun Lee, Won Sohn, Jemma Ahn, Dong-Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik

Clin Mol Hepatol. 2016;22(4):477-486. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0048

View: 9066 Download: 156 Web of Science: 23 Crossref: 21

Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization

Sun Hong Yoo, Jeong Won Jang, Jung Hyun Kwon, Seung Min Jung, Bohyun Jang, Jong Young Choi

Clin Mol Hepatol. 2016;22(4):458-465. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0054

View: 8790 Download: 134 Web of Science: 9 Crossref: 9

Comparison of hepatic MDCT, MRI, and DSA to explant pathology for the detection and treatment planning of hepatocellular carcinoma

Lauren M. Ladd, Temel Tirkes, Mark Tann, David M. Agarwal, Matthew S. Johnson, Bilal Tahir, Kumaresan Sandrasegaran

Clin Mol Hepatol. 2016;22(4):450-457. Published online December 14, 2016

DOI: https://doi.org/10.3350/cmh.2016.0036

View: 8977 Download: 157 Web of Science: 6 Crossref: 5

Glypican-3 level assessed by the enzyme-linked immunosorbent assay is inferior to alpha-fetoprotein level for hepatocellular carcinoma diagnosis

Yejoo Jeon, Eun Sun Jang, Yun Suk Choi, Jin-Wook Kim, Sook-Hyang Jeong

Clin Mol Hepatol. 2016;22(3):359-365. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0033

View: 12051 Download: 145 Web of Science: 20 Crossref: 19

Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B

Jaemin Lee, Sun Hong Yoo, Won Sohn, Hyung Woo Kim, Yong Sun Choi, Jung Ho Won, Jin Young Heo, Sang Jong Park, Young Min Park

Clin Mol Hepatol. 2016;22(3):339-349. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0021

View: 11583 Download: 162 Web of Science: 19 Crossref: 19

Editorial

Does obesity increase the risk of hepatocellular carcinoma in chronic hepatitis B patients?

Byoung Kuk Jang

Clin Mol Hepatol. 2016;22(3):336-338. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0104

View: 7896 Download: 115 Web of Science: 2 Crossref: 1

Review

The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy

Ioannis Varbobitis, George V. Papatheodoridis

Clin Mol Hepatol. 2016;22(3):319-326. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0045

View: 13244 Download: 393 Web of Science: 67 Crossref: 68

Original Article

Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma

Jun Young Kim, Dong Hyun Sinn, Geum-Youn Gwak, Gyu-Seong Choi, Aldosri Meshal Saleh, Jae-Won Joh, Sung Ki Cho, Sung Wook Shin, Keumhee Chough Carriere, Joong Hyun Ahn, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik

Clin Mol Hepatol. 2016;22(2):250-258. Published online June 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0015

View: 11323 Download: 198 Web of Science: 40 Crossref: 40

Review

Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma

Massimo Roncalli, Amedeo Sciarra, Luca Di Tommaso

Clin Mol Hepatol. 2016;22(2):199-211. Published online May 18, 2016

DOI: https://doi.org/10.3350/cmh.2016.0101

View: 18335 Download: 612 Web of Science: 40 Crossref: 37

Liver Imaging

Intraductal malignant tumors in the liver mimicking cholangiocarcinoma: Imaging features for differential diagnosis

Ah Yeong Kim, Woo Kyoung Jeong

Clin Mol Hepatol. 2016;22(1):192-197. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.192

View: 11547 Download: 231 Web of Science: 11 Crossref: 13

Original Article

Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis

Jung Min Lee, Byoung Kuk Jang, Yoo Jin Lee, Wang Yong Choi, Sei Myong Choi, Woo Jin Chung, Jae Seok Hwang, Koo Jeong Kang, Young Hwan Kim, Anil Kumar Chauhan, Soo Young Park, Won Young Tak, Young Oh Kweon, Byung Seok Kim, Chang Hyeong Lee

Clin Mol Hepatol. 2016;22(1):160-167. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.160

View: 11207 Download: 196 Web of Science: 79 Crossref: 69

Review

A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016

Su Jong Yu

Clin Mol Hepatol. 2016;22(1):7-17. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.7

View: 19778 Download: 544 Web of Science: 219 Crossref: 203

Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future

Hyun Young Woo, Jeong Heo

Clin Mol Hepatol. 2015;21(4):344-348. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.344

View: 8150 Download: 194 Web of Science: 27 Crossref: 25

Original Article

Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapy

Jung Gil Park

Clin Mol Hepatol. 2015;21(3):287-294. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.287

View: 8425 Download: 73 Web of Science: 26 Crossref: 28

Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease

Chansik An, Youn Ah Choi, Dongil Choi, Yong Han Paik, Sang Hoon Ahn, Myeong-Jin Kim, Seung Woon Paik, Kwang-Hyub Han, Mi-Suk Park

Clin Mol Hepatol. 2015;21(3):279-286. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.279

View: 12905 Download: 146 Web of Science: 59 Crossref: 58

Influence of P53 on the radiotherapy response of hepatocellular carcinoma

Ana R. Gomes, Ana M. Abrantes, Ana F. Brito, Mafalda Laranjo, João E. Casalta-Lopes, Ana C. Gonçalves, Ana B. Sarmento-Ribeiro, Maria F. Botelho, José G. Tralhão

Clin Mol Hepatol. 2015;21(3):257-267. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.257

View: 11192 Download: 117 Web of Science: 29 Crossref: 26

Editorial

P53 expression in hepatocellular carcinoma: influence on the radiotherapeutic response of the hepatocellular carcinoma

Yu Rim Lee, Soo Young Park

Clin Mol Hepatol. 2015;21(3):230-231. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.230

View: 6342 Download: 68 Web of Science: 12 Crossref: 10

Review

The mutational landscape of hepatocellular carcinoma

Ju-Seog Lee

Clin Mol Hepatol. 2015;21(3):220-229. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.220

View: 14016 Download: 381 Web of Science: 90 Crossref: 79

Personalized management of cirrhosis by non-invasive tests of liver fibrosis

Grace Lai-Hung Wong, Wendell Zaragoza Espinosa, Vicnent Wai-Sun Wong

Clin Mol Hepatol. 2015;21(3):200-211. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.200

View: 9529 Download: 125 Web of Science: 24 Crossref: 26

Original Article

The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study

Youn Zoo Cho, So Yeon Park, Eun Hee Choi, Soon Koo Baik, Sang Ok Kwon, Young Ju Kim, Seung Hwan Cha, Moon Young Kim

Clin Mol Hepatol. 2015;21(2):165-174. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.165

View: 9035 Download: 93 Web of Science: 17 Crossref: 16

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |

Viewed By 5527	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 4713	MAFLD: How is it different from NAFLD?
Viewed By 4446	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3644	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3615	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 78	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 57	MAFLD: How is it different from NAFLD?

Search